Differentiated Thyroid Cancer

The FDA granted priority review to cabozantinib for treatment of certain patients with differentiated thyroid cancer.

Adults with differentiated thyroid cancer who underwent hemithyroidectomy had lower risks for surgical complications compared with those who had total or near-total thyroidectomy, according to study data.

Providers should consider clinical context, including comorbidities, when diagnosing and managing thyroid cancer in older adults, according to a study published in Thyroid.

Adults with differentiated thyroid cancer had greater likelihood for severe COVID-19 outcomes with older age and at least one comorbidity, but cancer-related factors did not increase risks, according to a study findings.

In this video, Megan Haymart, MD, Professor of Medicine at the University of Michigan School of Medicine, discusses the relative lack of known risk factors for thyroid cancer, including family history and radiation exposure.